![Bruce Downey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bruce Downey
Direktor/Vorstandsmitglied bei
Putney, Inc.
Profil
Bruce L. Downey ist Partner bei NewSpring Health Capital II LP und Partner bei NSV II Management Co. LLC und im Vorstand von 5 weiteren Unternehmen. In der Vergangenheit war er Partner bei Winston & Strawn LLP, Partner bei Bishop, Cook, Purcell & Reynolds, Vorsitzender und Chief Executive Officer von Barr Pharmaceuticals, Inc. und Vorsitzender von Momenta Pharmaceuticals, Inc. sowie Leiter des US-Justizministeriums und Vorsitzender der Association for Accessible Medicines. Bruce L. Downey erhielt einen Graduiertenabschluss von der Ohio State University und einen Bachelorabschluss von der Miami University.
Aktive Positionen von Bruce Downey
| Unternehmen | Position | Beginn |
|---|---|---|
NewSpring Healthcare
 NewSpring Healthcare Investment ManagersFinance NewSpring Healthcare invests in lower-middle market companies located in the United States with a revenue of USD 10 - 100 million. The firm targets companies operating in the fields of behavioral health services, healthcare managed IT and outsourced pharma services sectors. It provides financing for recapitalizations, acquisitions and growth equity capital requirements. | Private Equity Investor | 01.04.2009 |
Putney, Inc.
 Putney, Inc. Pharmaceuticals: MajorHealth Technology Operates as a veterinary pharmaceutical company which specializes in the development of generic medicine for pets | Direktor/Vorstandsmitglied | - |
Acetylon Pharmaceuticals, Inc.
 Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical technology | Direktor/Vorstandsmitglied | - |
NewSpring Health Capital II LP
 NewSpring Health Capital II LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | 01.04.2009 |
NSV II Management Co. LLC
 NSV II Management Co. LLC Investment ManagersFinance Operates as a private equity investment firm | Corporate Officer/Principal | 01.04.2009 |
OncoPep, Inc.
 OncoPep, Inc. Investment ManagersFinance Functions as an alternative investment manager | Direktor/Vorstandsmitglied | 01.04.2011 |
Ehemalige bekannte Positionen von Bruce Downey
| Unternehmen | Position | Ende |
|---|---|---|
| C4 THERAPEUTICS, INC. | Vorsitzender | 07.06.2024 |
| CARDINAL HEALTH, INC. | Direktor/Vorstandsmitglied | 15.11.2023 |
| MOMENTA PHARMACEUTICALS, INC. | Vorsitzender | 01.10.2020 |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Bruce Downey
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
63
Beziehungen ersten Grades
18
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 18 |
|---|---|
Cardinal Health, Inc.
 Cardinal Health, Inc. Medical DistributorsDistribution Services Distributes pharmaceuticals and engages in manufacturing & sale of medical, surgical and laboratory supplies | Distribution Services |
Barr Pharmaceuticals, Inc.
 Barr Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Manufactures & sells generic prescription pharmaceutical products | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Putney, Inc.
Putney, Inc. Pharmaceuticals: MajorHealth Technology Operates as a veterinary pharmaceutical company which specializes in the development of generic medicine for pets | Health Technology |
NewSpring Health Capital II LP
NewSpring Health Capital II LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
OncoPep, Inc.
OncoPep, Inc. Investment ManagersFinance Functions as an alternative investment manager | Finance |
Winston & Strawn LLP
 Winston & Strawn LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Miami University
 Miami University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NSV II Management Co. LLC
NSV II Management Co. LLC Investment ManagersFinance Operates as a private equity investment firm | Finance |
US Department of Justice
 US Department of Justice General GovernmentGovernment Department of the United States government | Government |
Association for Accessible Medicines
 Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services Operate as a pharmaceutical association | Commercial Services |
Bishop, Cook, Purcell & Reynolds | |
NewSpring Healthcare
NewSpring Healthcare Investment ManagersFinance NewSpring Healthcare invests in lower-middle market companies located in the United States with a revenue of USD 10 - 100 million. The firm targets companies operating in the fields of behavioral health services, healthcare managed IT and outsourced pharma services sectors. It provides financing for recapitalizations, acquisitions and growth equity capital requirements. | Finance |
Acetylon Pharmaceuticals, Inc.
Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical technology | Health Technology |
Warner Chilcott Pharmaceuticals, Inc.
 Warner Chilcott Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Warner Chilcott Pharmaceuticals, Inc. is a company based in Mason. | Health Technology |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Melinta Therapeutics, Inc.
 Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage company and develops innovative therapies for acute and life-threatening illnesses | Health Technology |
Wählen Sie MarketScreener 
